STOCK TITAN

Cutera Appoints Stephana Patton as Chief Legal Officer

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary
Cutera, Inc. (Nasdaq: CUTR) announces the appointment of Stephana Patton, Ph.D., J.D. as Chief Legal Officer, effective November 13, 2023. Dr. Patton will lead legal, compliance, intellectual property, and human resources functions, bringing over two decades of legal experience in the life sciences industry. The appointment reflects Cutera's commitment to operational excellence, customer support, and growth of the AviClear franchise.
Positive
  • None.
Negative
  • None.

BRISBANE, Calif.--(BUSINESS WIRE)-- Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, is pleased to announce the appointment of Stephana Patton, Ph.D., J.D. as Chief Legal Officer, effective November 13, 2023.

Dr. Patton will report directly to Taylor Harris, Cutera’s Chief Executive Officer, and will be responsible for leading the legal, compliance, intellectual property and human resources functions. Dr. Patton brings over two decades of legal experience, focused on the life sciences industry both in private practice and as in-house counsel, to Cutera.

Taylor Harris, Chief Executive Officer, said, “I am thrilled to welcome Stephana to the Cutera team. Stephana has built a tremendous foundation of experience in the life science industry, including as general counsel for three publicly traded companies, which will serve our company well. In addition, she embodies the core values that our team has committed to as we lead Cutera into the next era.”

Dr. Patton said, “Cutera has a well-established leadership position in the aesthetics industry, and I’m excited to be part of the team that builds upon that legacy, with a focus on operational excellence in all areas, unparalleled support of our customers, and growth of the AviClear franchise.”

About Stephana Patton:

Stephana Patton, Ph.D., J.D. brings over twenty years of legal experience to Cutera. She was most recently Chief Legal Officer at InterVenn Biosciences. Prior to that, she served as General Counsel, Corporate Secretary, and Chief Compliance Officer at Eiger Biopharmaceuticals (NASDAQ:EIGR) where she was responsible for all legal and compliance matters. Previously, Dr. Patton was General Counsel, Corporate Secretary, and Chief Compliance Officer at BioTime, Inc. and Vice President, General Counsel and Commercial Compliance Officer at BioDelivery Sciences International, Inc. Dr. Patton began her life sciences industry career at Salix Pharmaceuticals, Inc., where she was Vice President of Intellectual Property and Licensing, until the company was acquired by Valeant, Inc. in 2015. She earned a B.S. in Chemistry from Erskine College, a Ph.D. in Biochemistry and Cell and Developmental Biology from Emory University, and a J.D. from Boston University School of Law.

About Cutera, Inc.

Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that harness the power of science and nature to enable medical practitioners to offer safe and effective treatments to their patients. For more information, call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.

Cutera, Inc.

Greg Barker

VP, Corporate FP&A and Investor Relations

415-657-5500

IR@cutera.com

Source: Cutera, Inc.

Stephana Patton, Ph.D., J.D. is the new Chief Legal Officer of Cutera, Inc.

Stephana Patton will assume her new role as Chief Legal Officer on November 13, 2023.

Dr. Patton will be responsible for leading the legal, compliance, intellectual property, and human resources functions at Cutera.

Dr. Patton brings over two decades of legal experience in the life sciences industry to Cutera.

Dr. Patton embodies the core values of operational excellence, unparalleled customer support, and growth of the AviClear franchise at Cutera.
Eiger BioPharmaceuticals Inc

NASDAQ:EIGR

EIGR Rankings

EIGR Latest News

EIGR Stock Data

Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
Health Technology, Biotechnology, Manufacturing, Biological Product (except Diagnostic) Manufacturing
US
Palo Alto

About EIGR

eiger inc is a research company located in 500 crescent ct ste 300, dallas, texas, united states.